A. Ahnaou

发表

BrainStar: towards a miniaturized microsystem for wireless brain stimulation and recording in small animal models

J. Vanfleteren, Wolfgang Eberle, Alexandru Andrei, 2012 .

Ketamine: differential neurophysiological dynamics in functional networks in the rat brain

W. Drinkenburg, H. Huysmans, N. Manyakov, 2017, Translational Psychiatry.

Population pharmacokinetic model of fluvoxamine in rats: utility for application in animal behavioral studies.

M. Danhof, W. Drinkenburg, M. Geldof, 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Correction for Model Selection Bias Using a Modified Model Averaging Approach for Supervised Learning Methods Applied to EEG Experiments

G. Molenberghs, H. Geys, L. Bijnens, 2010, Journal of biopharmaceutical statistics.

Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer’s disease pathology

W. Drinkenburg, D. Moechars, N. Manyakov, 2017, Scientific Reports.

19th biennial IPEG Meeting

Asbjørn Mohr Drewes, Vitoantonio Bevilacqua, Roshan Cools, 2016 .

Long‐term enhancement of REM sleep by the pituitary adenylyl cyclase‐activating polypeptide (PACAP) in the pontine reticular formation of the rat

H. Vaudry, M. Hamon, P. Bourgin, 1999, The European journal of neuroscience.

Anti-Parkinson effects of a selective alpha2C-adrenoceptor antagonist in the MPTP marmoset model

W. Drinkenburg, I. Philippens, A. Ahnaou, 2014, Behavioural Brain Research.

Discovery of VU0409551/JNJ-46778212: An mGlu5 Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia.

A. Megens, X. Langlois, J. Bartolomé-Nebreda, 2015, ACS medicinal chemistry letters.

Microsoft Word-32670823-file00.docx

T. Daigle, C. Mackie, H. Lavreysen, 2013 .

Translational evaluation of JNJ-18038683, a 5-HT7 receptor antagonist, on REM sleep and in major depressive disorder

P. Bonaventure, C. Dvorak, T. Lovenberg, 2012 .

REM sleep and in major depressive disorder

P. Bonaventure, W. Chai, C. Dvorak, 2012 .

Tachykinin NK3 receptor agonists induced microvascular leakage hypersensitivity in the guinea-pig airways

V. Lagente, E. Naline, A. Ahnaou, 2001 .

Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM).

María Lourdes Linares, G. Macdonald, M. Somers, 2016, Journal of medicinal chemistry.

Immunocytochemical Distribution of VIP and PACAP in the Rat Brain Stem

H. Vaudry, M. Hamon, J. Hannibal, 2006, Annals of the New York Academy of Sciences.

Rapid eye movement sleep induction by vasoactive intestinal peptide infused into the oral pontine tegmentum of the rat may involve muscarinic receptors

M. Hamon, P. Bourgin, A. Ahnaou, 1999, Neuroscience.

Relevance of the metabotropic glutamate receptor (mGluR5) in the regulation of NREM-REM sleep cycle and homeostasis: Evidence from mGluR5 (−/−) mice

T. Steckler, A. Ahnaou, L. Raeymaekers, 2015, Behavioural Brain Research.

Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer’s disease pathology

W. Drinkenburg, D. Moechars, N. Manyakov, 2017, Scientific Reports.

Pharmacological and pharmacokinetic properties of JNJ-40411813, a positive allosteric modulator of the mGlu2 receptor

X. Langlois, H. Lavreysen, W. Drinkenburg, 2014, Pharmacology research & perspectives.

A Comparison of Doubly Hierarchical Discriminant Analyses for Multiple Class Longitudinal Data from EEG Experiments

G. Molenberghs, L. Bijnens, W. Drinkenburg, 2008, Journal of biopharmaceutical statistics.

Blocking melanin-concentrating hormone MCH1 receptor affects rat sleep-wake architecture.

T. Steckler, W. Drinkenburg, J. Alcázar, 2008, European journal of pharmacology.

Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture.

H. Geys, T. Steckler, W. Drinkenburg, 2009, European journal of pharmacology.

Discovery of 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic glutamate 2 receptor.

María Lourdes Linares, A. Megens, G. Macdonald, 2012, Journal of medicinal chemistry.

How to Keep the Brain Awake? The Complex Molecular Pharmacogenetics of Wake Promotion

S. Pradervand, M. Tafti, P. Franken, 2009, Neuropsychopharmacology.

Discovery and Kinetic Profiling of 7-Aryl-1,2,4-triazolo[4,3-a]pyridines: Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2.

A. IJzerman, T. Mulder-Krieger, L. Heitman, 2017, Journal of medicinal chemistry.

Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782

A. Megens, X. Langlois, G. Macdonald, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Muscarinic and PACAP receptor interactions at pontine level in the rat: significance for REM sleep regulation

M. Hamon, P. Escourrou, S. Ballet, 2000, The European journal of neuroscience.

Translational Evaluation of JNJ-18038683, a 5-Hydroxytryptamine Type 7 Receptor Antagonist, on Rapid Eye Movement Sleep and in Major Depressive Disorder

P. Bonaventure, C. Dvorak, T. Lovenberg, 2012, Journal of Pharmacology and Experimental Therapeutics.

Effects of phosphodiesterase 10 inhibition on striatal cyclic AMP and peripheral physiology in rats.

T. Meert, G. Vanhoof, H. Geys, 2010, Acta neurobiologiae experimentalis.

Title: N -aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in pre-clinical models of NMDA hypofunction and cognitive enhancement

T. Daigle, C. Mackie, H. Lavreysen, 2013 .